These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22636676)

  • 21. Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation.
    Stelzer JE; Patel JR; Walker JW; Moss RL
    Circ Res; 2007 Aug; 101(5):503-11. PubMed ID: 17641226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel function of cardiac protein kinase D1 as a dynamic regulator of Ca2+ sensitivity of contraction.
    Goodall MH; Wardlow RD; Goldblum RR; Ziman A; Lederer WJ; Randall W; Rogers TB
    J Biol Chem; 2010 Dec; 285(53):41686-700. PubMed ID: 21041300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes.
    Pohlmann L; Kröger I; Vignier N; Schlossarek S; Krämer E; Coirault C; Sultan KR; El-Armouche A; Winegrad S; Eschenhagen T; Carrier L
    Circ Res; 2007 Oct; 101(9):928-38. PubMed ID: 17823372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of in vivo left ventricular [correction] contraction/relaxation kinetics by myosin binding protein C: protein kinase A phosphorylation dependent and independent regulation.
    Nagayama T; Takimoto E; Sadayappan S; Mudd JO; Seidman JG; Robbins J; Kass DA
    Circulation; 2007 Nov; 116(21):2399-408. PubMed ID: 17984378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Kinase D Plays a Crucial Role in Maintaining Cardiac Homeostasis by Regulating Post-Translational Modifications of Myofilament Proteins.
    Herwig M; Begovic M; Budde H; Delalat S; Zhazykbayeva S; Sieme M; Schneider L; Jaquet K; Mügge A; Akin I; El-Battrawy I; Fielitz J; Hamdani N
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background.
    Sadayappan S; Gulick J; Klevitsky R; Lorenz JN; Sargent M; Molkentin JD; Robbins J
    Circulation; 2009 Mar; 119(9):1253-62. PubMed ID: 19237661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue.
    de Lange WJ; Grimes AC; Hegge LF; Ralphe JC
    J Gen Physiol; 2013 Jan; 141(1):73-84. PubMed ID: 23277475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction.
    van Dijk SJ; Dooijes D; dos Remedios C; Michels M; Lamers JM; Winegrad S; Schlossarek S; Carrier L; ten Cate FJ; Stienen GJ; van der Velden J
    Circulation; 2009 Mar; 119(11):1473-83. PubMed ID: 19273718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of cMyBP-C affects contractile mechanisms in a site-specific manner.
    Wang L; Ji X; Barefield D; Sadayappan S; Kawai M
    Biophys J; 2014 Mar; 106(5):1112-22. PubMed ID: 24606935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal cardiac contraction in mice lacking the proline-alanine rich region and C1 domain of cardiac myosin binding protein C.
    van Dijk SJ; Witt CC; Harris SP
    J Mol Cell Cardiol; 2015 Nov; 88():124-32. PubMed ID: 26455481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute exposure to progesterone attenuates cardiac contraction by modifying myofilament calcium sensitivity in the female mouse heart.
    Feridooni HA; MacDonald JK; Ghimire A; Pyle WG; Howlett SE
    Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H46-H59. PubMed ID: 27793852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
    Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GSK3β phosphorylates newly identified site in the proline-alanine-rich region of cardiac myosin-binding protein C and alters cross-bridge cycling kinetics in human: short communication.
    Kuster DW; Sequeira V; Najafi A; Boontje NM; Wijnker PJ; Witjas-Paalberends ER; Marston SB; Dos Remedios CG; Carrier L; Demmers JA; Redwood C; Sadayappan S; van der Velden J
    Circ Res; 2013 Feb; 112(4):633-9. PubMed ID: 23277198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C.
    Stelzer JE; Patel JR; Moss RL
    Circ Res; 2006 Oct; 99(8):884-90. PubMed ID: 16973906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility.
    Lynch TL; Kumar M; McNamara JW; Kuster DWD; Sivaguru M; Singh RR; Previs MJ; Lee KH; Kuffel G; Zilliox MJ; Lin BL; Ma W; Gibson AM; Blaxall BC; Nieman ML; Lorenz JN; Leichter DM; Leary OP; Janssen PML; de Tombe PP; Gilbert RJ; Craig R; Irving T; Warshaw DM; Sadayappan S
    J Mol Cell Cardiol; 2021 Jul; 156():33-44. PubMed ID: 33781820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Slowing of contractile kinetics by myosin-binding protein C can be explained by its cooperative binding to the thin filament.
    Wang C; Schwan J; Campbell SG
    J Mol Cell Cardiol; 2016 Jul; 96():2-10. PubMed ID: 26454159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes.
    Sheehan KA; Ke Y; Wolska BM; Solaro RJ
    Am J Physiol Cell Physiol; 2009 Jan; 296(1):C47-58. PubMed ID: 18923061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of site-specific phosphorylation of protein kinase A sites Ser23 and Ser24 of cardiac troponin I in human cardiomyocytes.
    Wijnker PJ; Foster DB; Tsao AL; Frazier AH; dos Remedios CG; Murphy AM; Stienen GJ; van der Velden J
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H260-8. PubMed ID: 23144315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
    Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
    J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of SR33805 in failing myocardium.
    Ait Mou Y; Toth A; Cassan C; Czuriga D; de Tombe PP; Papp Z; Lacampagne A; Cazorla O
    Cardiovasc Res; 2011 Aug; 91(3):412-9. PubMed ID: 21467075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.